Perrigo (PRGO) Cash & Equivalents Growth (1y) (2013 - 2026)
Perrigo (PRGO) Cash & Equivalents Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | -39.02% |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 120.45% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 12.78% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 50.32% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -32.64% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 138.97% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 37.30% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -12.11% |
| 10 | Perrigo | 1.42 Bn | 1.06 Bn | 325.50 Mn | -12.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -12.86% |
| Dec 31, 2025 | -4.87% |
| Sep 27, 2025 | -70.47% |
| Jun 28, 2025 | -16.32% |
| Mar 29, 2025 | -37.75% |
| Dec 31, 2024 | -25.62% |
| Sep 28, 2024 | 144.61% |
| Jun 29, 2024 | -2.23% |
| Mar 30, 2024 | 19.08% |
| Dec 31, 2023 | 25.07% |
| Sep 30, 2023 | 27.65% |
| Jul 1, 2023 | 14.40% |
| Apr 1, 2023 | -71.86% |
| Dec 31, 2022 | -67.79% |
| Oct 1, 2022 | -77.45% |
| Jul 2, 2022 | 52.85% |
| Apr 2, 2022 | 317.39% |
| Dec 31, 2021 | 195.31% |
| Oct 2, 2021 | 144.66% |
| Jul 3, 2021 | -78.20% |